Stock Scorer

10x Genomics, Inc. (TXG)

10x Genomics, Inc. reported revenue of 151M USD for the quarter ending 30 June 2026, down 12.6% from 172.9M a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 June 2026 151M -12.6%
Gross Profit Q2 '26 · ending 30 June 2026 112.5M -10.1%
Operating Income Q2 '26 · ending 30 June 2026 -19.6M -164.9%
Net Income Q2 '26 · ending 30 June 2026 -17.9M -151.9%
Cost of Revenue Q2 '26 · ending 30 June 2026 38.5M -19.4%
Operating Cash Flow Q2 '26 · ending 30 June 2026 17M -4.1%
Free Cash Flow Q2 '26 · ending 30 June 2026 15.4M -4.6%
Shares Outstanding Q2 '26 · ending 30 June 2026 130M +6.0%
EPS Q2 '26 · ending 30 June 2026 -0.59 —

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 642.8M-61M-43.5M130.1M
20242024-12-31 610.8M-194.6M-182.6M-5.7M
20232023-12-31 618.7M-265.3M-255.1M-63.8M
20222022-12-31 516.4M-167.9M-166M-165.3M
20212021-12-31 490.5M-52.3M-58.2M-122.7M
20202020-12-31 298.8M-534.1M-542.7M-254.6M
20192019-12-31 245.9M-30.6M-31.3M-8.1M
20182018-12-31 146.3M-110.8M-112.5M-82.7M
20172017-12-31 71.1M-18.4M-18.8M-14.5M

Every period

Revenue Quarterly

PeriodEndingRevenue
Q2 '262026-06-30151M
Q1 '262026-03-31150.8M
Q4 '252025-12-31166M
Q3 '252025-09-30149M
Q2 '252025-06-30172.9M
Q1 '252025-03-31154.9M
Q4 '242024-12-31165M
Q3 '242024-09-30151.7M
Q2 '242024-06-30153.1M
Q1 '242024-03-31141M
Q4 '232023-12-31184M
Q3 '232023-09-30153.6M
Q2 '232023-06-30146.8M
Q1 '232023-03-31134.3M
Q4 '222022-12-31156.2M
Q3 '222022-09-30131.1M
Q2 '222022-06-30114.6M
Q1 '222022-03-31114.5M
Q4 '212021-12-31143.5M
Q3 '212021-09-30125.3M

Gross Profit Quarterly

PeriodEndingGross Profit
Q2 '262026-06-30112.5M
Q1 '262026-03-31106.2M
Q4 '252025-12-31113M
Q3 '252025-09-30100.3M
Q2 '252025-06-30125.1M
Q1 '252025-03-31105.4M
Q4 '242024-12-31111M
Q3 '242024-09-30106.4M
Q2 '242024-06-30104.2M
Q1 '242024-03-3192.9M
Q4 '232023-12-31115.8M
Q3 '232023-09-3095.5M
Q2 '232023-06-3099.6M
Q1 '232023-03-3198.4M
Q4 '222022-12-31119.4M
Q3 '222022-09-30100.7M
Q2 '222022-06-3086.9M
Q1 '222022-03-3189M
Q4 '212021-12-31115.9M
Q3 '212021-09-30100.8M

Operating Income Quarterly

PeriodEndingOperating Income
Q2 '262026-06-30-19.6M
Q1 '262026-03-31-17M
Q4 '252025-12-31-19.5M
Q3 '252025-09-30-32.2M
Q2 '252025-06-3030.1M
Q1 '252025-03-31-39.3M
Q4 '242024-12-31-49.8M
Q3 '242024-09-30-41.5M
Q2 '242024-06-30-41.7M
Q1 '242024-03-31-61.5M
Q4 '232023-12-31-55.2M
Q3 '232023-09-30-94.8M
Q2 '232023-06-30-63.4M
Q1 '232023-03-31-52M
Q4 '222022-12-31-23.1M
Q3 '222022-09-30-40M
Q2 '222022-06-30-63.1M
Q1 '222022-03-31-41.7M
Q4 '212021-12-31-15.8M
Q3 '212021-09-30-15.9M

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-30-17.9M
Q1 '262026-03-31-13.5M
Q4 '252025-12-31-16.3M
Q3 '252025-09-30-27.5M
Q2 '252025-06-3034.5M
Q1 '252025-03-31-34.4M
Q4 '242024-12-31-49M
Q3 '242024-09-30-35.8M
Q2 '242024-06-30-37.9M
Q1 '242024-03-31-59.9M
Q4 '232023-12-31-49M
Q3 '232023-09-30-93M
Q2 '232023-06-30-62.4M
Q1 '232023-03-31-50.7M
Q4 '222022-12-31-17.2M
Q3 '222022-09-30-41.9M
Q2 '222022-06-30-64.5M
Q1 '222022-03-31-42.4M
Q4 '212021-12-31-18.4M
Q3 '212021-09-30-17.2M

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q2 '262026-06-3038.5M
Q1 '262026-03-3144.7M
Q4 '252025-12-3153M
Q3 '252025-09-3048.7M
Q2 '252025-06-3047.8M
Q1 '252025-03-3149.4M
Q4 '242024-12-3154.1M
Q3 '242024-09-3045.3M
Q2 '242024-06-3048.9M
Q1 '242024-03-3148.1M
Q4 '232023-12-3168.2M
Q3 '232023-09-3058.1M
Q2 '232023-06-3047.2M
Q1 '232023-03-3135.9M
Q4 '222022-12-3136.8M
Q3 '222022-09-3030.4M
Q2 '222022-06-3027.7M
Q1 '222022-03-3125.5M
Q4 '212021-12-3127.6M
Q3 '212021-09-3024.5M

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-3017M
Q1 '262026-03-3126.1M
Q4 '252025-12-3140.8M
Q3 '252025-09-3043.2M
Q2 '252025-06-3017.7M
Q1 '252025-03-3134.4M
Q4 '242024-12-31-6.7M
Q3 '242024-09-3021.6M
Q2 '242024-06-307.5M
Q1 '242024-03-31-15.7M
Q4 '232023-12-3125.8M
Q3 '232023-09-30-25.3M
Q2 '232023-06-30-11.5M
Q1 '232023-03-31-4.1M
Q4 '222022-12-3113.7M
Q3 '222022-09-30-9.6M
Q2 '222022-06-30-17M
Q1 '222022-03-31-20.8M
Q4 '212021-12-315.8M
Q3 '212021-09-30-26.2M

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q2 '262026-06-3015.4M
Q1 '262026-03-3124.5M
Q4 '252025-12-3139M
Q3 '252025-09-3042.5M
Q2 '252025-06-3016.1M
Q1 '252025-03-3132.5M
Q4 '242024-12-31-9.5M
Q3 '242024-09-3017.8M
Q2 '242024-06-304.6M
Q1 '242024-03-31-18.6M
Q4 '232023-12-3122.3M
Q3 '232023-09-30-40.5M
Q2 '232023-06-30-36.9M
Q1 '232023-03-31-8.7M
Q4 '222022-12-31-26M
Q3 '222022-09-30-46.1M
Q2 '222022-06-30-44.2M
Q1 '222022-03-31-48.9M
Q4 '212021-12-31-21.8M
Q3 '212021-09-30-46.4M

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q2 '262026-06-30130M
Q1 '262026-03-31128.3M
Q3 '252025-09-30125.5M
Q2 '252025-06-30124.5M
Q1 '252025-03-31122.6M
Q3 '242024-09-30120.7M
Q2 '242024-06-30120.1M
Q1 '242024-03-31119.4M
Q3 '232023-09-30117.7M
Q2 '232023-06-30116.7M
Q1 '232023-03-31115.6M
Q3 '222022-09-30114.1M
Q2 '222022-06-30113.6M
Q1 '222022-03-31113M
Q3 '212021-09-30110.9M
Q2 '212021-06-30109.9M
Q1 '212021-03-31108.7M
Q3 '202020-09-30101.3M
Q2 '202020-06-3099M
Q1 '202020-03-3196.8M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q2 '262026-06-30-0.59
Q1 '262026-03-31-0.17
Q4 '252025-12-31-0.35
Q3 '252025-09-30-0.63
Q2 '252025-06-30-0.71
Q1 '252025-03-31-1.31
Q4 '242024-12-31-1.53
Q3 '242024-09-30-1.53
Q2 '242024-06-30-2.02
Q1 '242024-03-31-2.23
Q4 '232023-12-31-2.17
Q3 '232023-09-30-1.91
Q2 '232023-06-30-1.49
Q1 '232023-03-31-1.53
Q4 '222022-12-31-1.47
Q3 '222022-09-30-1.49
Q2 '222022-06-30-1.27
Q1 '222022-03-31-0.80
Q4 '212021-12-31-0.53
Q3 '212021-09-30-4.45